Hyperglycemia Global Clinical Trials Review, H2, 2011


October 11, 2011
90 Pages - SKU: GBDT6620490
License type:
Table of Contents Search inside this report Related Reports
Pulmonary Tuberculosis – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Pulmonary Tuberculosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Pulmonary Tuberculosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Pulmonary Tuberculosis,  |  read more...
$2,000.00
Streptococcus Pneumoniae Infection – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Streptococcus Pneumoniae Infection – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Streptococcus Pneumoniae Infection - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for  |  read more...
$2,000.00
Muscle Atrophy – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Muscle Atrophy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Muscle Atrophy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Muscle Atrophy,  |  read more...
$2,000.00
Metastatic Ovarian Cancer – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Metastatic Ovarian Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Ovarian Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for  |  read more...
$2,000.00
Influenza B Infections – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Influenza B Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Influenza B Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for  |  read more...
$2,000.00
Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic  |  read more...
$2,000.00
China Pharmaceutical Guidebook Series (4) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medi
5/20/2013 | published by: Access China Management Consulting Ltd.
The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition of traditional Chinese medicines almost can not been expressed by  |  read more...
$750.00
Primary Systemic Amyloidosis – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Primary Systemic Amyloidosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Primary Systemic Amyloidosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for  |  read more...
$2,000.00
Vitiligo – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Vitiligo – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Vitiligo - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Vitiligo, complete with latest  |  read more...
$2,000.00
Cardiac Fibrosis – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Cardiac Fibrosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cardiac Fibrosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cardiac Fibrosis,  |  read more...
$2,000.00
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Clinical Trial Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!